@article{5573,
  keywords = {Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Follow-Up Studies, Humans, leprosy, Long-Term Care, Male, Peripheral Nervous System Diseases, Prednisolone, Randomized Controlled Trials as Topic, Recovery of Function, Risk Assessment, Sensation Disorders, Severity of Illness Index, Time Factors, Treatment Outcome},
  author = {Naafs B},
  title = {Treatment duration of reversal reaction: a reappraisal. Back to the past.},
  abstract = {<p>In this paper, earlier data on the length of prednisolone treatment are re-examined. Based on those data and supported by the literature and the author's own observations, it can be concluded that type I leprosy reaction should be treated with prednisolone for a longer period than the 12 weeks, advised by the WHO. The paper also warns against silent nerve damage that may occur when prednisolone is discontinued early.</p>},
  year = {2003},
  journal = {Leprosy review},
  volume = {74},
  pages = {328-36},
  month = {2003 Dec},
  issn = {0305-7518},
  url = {https://leprosyreview.org/article/74/4/32-8336},
  language = {eng},
}